Al Shaer Danah, Al Musaimi Othman, Albericio Fernando, de la Torre Beatriz G
KRISP, School of Laboratory of Medicine and Medical Science, College of Health Sciences, University of KwaZulu-Natal, Durban 4001, South Africa.
School of Chemistry and Physics, University of KwaZulu-Natal, Durban 4001, South Africa.
Pharmaceuticals (Basel). 2019 Apr 5;12(2):52. doi: 10.3390/ph12020052.
In 2018, the United States Food and Drug Administration (FDA) approved a total of 59 new drugs, three of them (5%) are TIDES (or also, -tides), two oligonucleotides and one peptide. Herein, the three TIDES approved are analyzed in terms of medical target, mode of action, chemical structure, and economics.
2018年，美国食品药品监督管理局（FDA）总共批准了59种新药，其中三种（5%）是TIDES（或者也叫-tides），两种是寡核苷酸，一种是肽。在此，对获批的这三种TIDES药物在医学靶点、作用方式、化学结构和经济学方面进行分析。
